Nishant Tageja

Nishant Tageja

University of Pittsburgh - Pittsburgh / United States
Others
AD Scientific Index ID: 4703476
person_outline Nishant Tageja's MOST POPULAR ARTICLES
1-) Treatment with carfilzomib-lenalidomide-dexamethasone with lenalidomide extension in patients with smoldering or newly diagnosed multiple myelomaN Korde, M Roschewski, A Zingone, M Kwok, EE Manasanch, M Bhutani, ...JAMA oncology 1 (6), 746-754, 20153022015
2-) A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myelomaN Korde, M Carlsten, MJ Lee, A Minter, E Tan, M Kwok, E Manasanch, ...Haematologica 99 (6), e81, 20141272014
3-) Flow cytometric differentiation of abnormal and normal plasma cells in the bone marrow in patients with multiple myeloma and its precursor diseasesPR Tembhare, CM Yuan, D Venzon, R Braylan, N Korde, E Manasanch, ...Leukemia research 38 (3), 371-376, 2014892014
4-) Bendamustine: something old, something newN Tageja, J NagiCancer chemotherapy and pharmacology 66, 413-423, 2010992010
5-) Phase II clinical and correlative study of carfilzomib, lenalidomide, and dexamethasone followed by lenalidomide extended dosing (CRD-R) induces high rates of MRD negativity in …N Korde, A Zingone, ML Kwok, EE Manasanch, M Bhutani, N Tageja, ...Blood 122 (21), 538, 2013692013